Synovate Healthcare appoints Dr Nicole Oehlrich
pharmafile | November 18, 2010 | Appointment | Medical Communications, Sales and Marketing | Dr Nicole Oehlrich, appointment, medical communications, oncology market research, sales and marketing, synovate
Global market research agency Synovate has appointed Dr Nicole Oehlrich to the role of oncology business consultant for its specialist Global Oncology practice within its Healthcare research division.
Having earned her doctorate while working for the German Cancer Research Centre, Nicole has worked with Merck Pharma as medical manager of oncology, and IMS as product manager of oncology.
At Synovate Nicole will develop the firm’s business for both syndicated and ad hoc oncology research in Germany, and support its local and European pharmaceutical and healthcare clients.
Jackie Ilacqua, senior VP and head of global oncology at Synovate, said: “We are very excited to have Dr Oehlrich on board. Her strong oncology expertise coupled with her deep understanding of the German and other European markets will ensure that our clients in Europe receive the highest level of service and customised oncology solutions that meet their needs.”
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






